IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
By MedImaging International staff writers Posted on 14 Feb 2024 |
Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered into an agreement to acquire all the assets of Radcal Corporation (Monrovia, CA, USA), a leader in diagnostic X-ray measurement. With the acquisition of Radcal, IBA will further strengthen its Medical Imaging Quality Assurance offering as well as its presence in the US market.
Radcal, a pioneer in the X-ray imaging market, introduced the first instrument to provide comprehensive measures of X-ray dose with the capability to interchange sensors without any loss in accuracy, almost 50 years ago. The integration of Radcal into IBA’s business will aid its continued growth in the dosimetry and quality assurance field, further strengthening its foothold in the key US market and expanding its product offering beyond OEM and into the clinical setting.
“This acquisition strengthens our position as a global leader in Medical Imaging Dosimetry and Quality Assurance, complementing our leading position in the radiotherapy market and diversifying our revenue sources,” said Olivier Legrain, Chief Executive Officer at IBA. “We see tremendous potential for the combined business both in the US and the international market and look forward to working closely with the Radcal team to continue the strong growth of its leading offering.”
“We are delighted to welcome the talented and dedicated Radcal team to IBA group,” added Jean-Marc Bothy, President of IBA Dosimetry. “We are committed to providing the very best in medical imaging and radiotherapy quality assurance to our customers globally, contributing to our ultimate goal to treat more patients safely. Radcal’s growing product offering will enable us to reach new customers in the US and expand our presence in the Medical Imaging Quality Assurance market internationally.”
Related Links:
IBA
Radcal Corporation
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases